Skip to content
Screener

Operating Income at other companies

Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
$2.09B
Danaher logo
DanaherDHR
$1.13B+48.3%
Repligen logo
RepligenRGEN
$13.98M+0.6%
Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO
$34.1M+43.9%
Ginkgo Bioworks logo
Ginkgo BioworksDNA
-$58.55M-0.7%
Charles River Laboratories logo
Charles River LaboratoriesCRL
$119.89M+19.7%

Other financials

Income statement

See full
Revenue$51.4M+8.5%
Gross profit$20.7M+166%
Net income-$12.4M+68.6%
EPS (diluted)-$0.08+70.4%

Balance sheet

See full
Cash & equivalents$70.6M-73.8%
Total debt$176.7M-52.4%
Total equity$204.6M-23.0%
Total assets$603.7M-32.7%

Cash flow

See full
Operating cash flow$4.0M+139%
CapEx$370.0K-87.1%
Free cash flow$3.6M+128%

Valuation

See full
Market cap$918.96M+210%
Enterprise value$1.03B+158%
P/S4.4×+3.1×

Profitability

See full
Gross margin34.9%+4.4pp
Operating margin-56.1%-21.3pp
Net margin-37.1%-13.6pp
FCF margin-17.2%

Returns & leverage

See full
Return on equity-32.9%-9.4pp
Debt / equity0.9×-0.5×
Current ratio4.1×-1.1×

Where this comes from

Reported directly by Maravai LifeSciences Holdings, Inc. in its filing.

Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.

The source filing: Maravai LifeSciences Holdings, Inc.’s 10-Q, filed August 7, 2026.

Filed
Aug 7, 2026, 4:03 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001823239-26-000059
Line itemThree Months Ended June 30, 2026Three Months Ended June 30, 2025Six Months Ended June 30, 2026Six Months Ended June 30, 2025
Goodwill impairment30,44942,884
Restructuring(33)2,845
Total operating expenses35,73974,04671,598130,933
Loss from operations(15,089)(66,278)(17,247)(115,440)
Other income (expense):
Interest expense(4,809)(6,815)(10,558)(13,593)
Interest income1,1593,0303,0326,255
Loss on extinguishment of debt(3,011)(3,413)

Item 1. Financial Statements

FAQ

What is Maravai LifeSciences Holdings, Inc.'s operating income?
Maravai LifeSciences Holdings, Inc. (MRVI) reported operating income of -$15.09M in Q2 2026.
How has Maravai LifeSciences Holdings, Inc.'s operating income changed year-over-year?
Maravai LifeSciences Holdings, Inc.'s operating income increased by 77.2% year-over-year, from -$66.28M to -$15.09M.
What is the long-term trend for Maravai LifeSciences Holdings, Inc.'s operating income?
Over 4 years (2021 to 2025), Maravai LifeSciences Holdings, Inc.'s operating income has grown at a -21.1% compound annual growth rate (CAGR), from $554.65M to -$215.27M.
What does operating income mean?
Gross profit minus all operating expenses (SG&A, R&D, D&A). Measures the profit from core business operations before interest, taxes, and non-operating items.

Ask your AI about Maravai LifeSciences Holdings, Inc.'s operating income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude